标题
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
作者
关键词
-
出版物
Expert Review of Anti-Infective Therapy
Volume 11, Issue 2, Pages 159-177
出版商
Informa UK Limited
发表日期
2013-02-15
DOI
10.1586/eri.12.162
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
- (2012) Marilyn N. Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
- (2012) Meredith G. Jernigan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
- (2012) D. F. Florescu et al. CLINICAL INFECTIOUS DISEASES
- Editorial Commentary: Closing the Loop--A Colistin Clinical Study to Confirm Dosing Recommendations From PK/PD Modeling
- (2012) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria
- (2012) M. Akova et al. CLINICAL MICROBIOLOGY AND INFECTION
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Improving known classes of antibiotics: an optimistic approach for the future
- (2012) Karen Bush CURRENT OPINION IN PHARMACOLOGY
- Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit
- (2012) B. D. Debby et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects
- (2012) G. Chandorkar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
- (2012) Fekade Sime et al. Annals of Intensive Care
- An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: From theory to practice
- (2011) Pnina Ciobotaro et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
- (2011) Abraham Borer et al. AMERICAN JOURNAL OF INFECTION CONTROL
- In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
- (2011) Maria Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase
- (2011) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Appraising Contemporary Strategies to Combat Multidrug Resistant Gram-Negative Bacterial Infections–Proceedings and Data From the Gram-Negative Resistance Summit
- (2011) Marin H. Kollef et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
- (2011) N. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin pharmacokinetics: the fog is lifting
- (2011) W. Couet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
- (2011) D. Ben-David et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dosing of colistin—back to basic PK/PD
- (2011) Phillip J Bergen et al. CURRENT OPINION IN PHARMACOLOGY
- Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2011) Elizabeth A. Neuner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae
- (2011) George A. Pankey et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
- (2011) G. Samonis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
- (2011) Debby Ben-David et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals
- (2011) Youri Glupczynski et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotic dosing in critical illness
- (2011) C. McKenzie JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients
- (2011) G.B. Orsi et al. JOURNAL OF HOSPITAL INFECTION
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
- (2011) Timothy R Walsh et al. LANCET INFECTIOUS DISEASES
- Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides
- (2011) Luke F. Chen et al. MEDICAL CLINICS OF NORTH AMERICA
- Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
- (2011) Ioannis A. Bliziotis et al. PLoS One
- Over-treatment of carbapenemase-producing Enterobacteriaceae
- (2011) Deba S. Rihani et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- The emerging NDM carbapenemases
- (2011) Patrice Nordmann et al. TRENDS IN MICROBIOLOGY
- Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel
- (2010) A. Leavitt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
- (2010) J. B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
- (2010) Roberto Imberti et al. CHEST
- Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
- (2010) Diamantis P. Kofteridis et al. CLINICAL INFECTIOUS DISEASES
- How Soon Is Now? The Urgent Need for Randomized, Controlled Trials Evaluating Treatment of Multidrug‐Resistant Bacterial Infection
- (2010) David L. Paterson et al. CLINICAL INFECTIOUS DISEASES
- Rifampin Combination Therapy for Nonmycobacterial Infections
- (2010) G. N. Forrest et al. CLINICAL MICROBIOLOGY REVIEWS
- A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
- (2010) Anand Kumar et al. CRITICAL CARE MEDICINE
- Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
- (2010) May Nguyen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Management of antibiotic resistance in the intensive care unit setting
- (2010) Nicola Petrosillo et al. Expert Review of Anti-Infective Therapy
- Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes
- (2010) Eleni Mouloudi et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Intravenous colistimethate administration and colistin lung tissue concentrations
- (2010) Roberto Imberti INTENSIVE CARE MEDICINE
- Adverse events associated with intravenous fosfomycin
- (2010) Amélie Florent et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
- (2010) F. Perez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
- (2010) A. Elemam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin
- (2010) Romney M. Humphries et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?
- (2009) M. Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
- (2009) R. V. Dudhani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
- (2009) B. Kitchel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Resistance among and Therapeutic Options against Gram‐Negative Pathogens
- (2009) James J. Rahal CLINICAL INFECTIOUS DISEASES
- An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
- (2009) Maria Souli et al. CLINICAL INFECTIOUS DISEASES
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline
- (2009) April Barbour et al. CLINICAL PHARMACOKINETICS
- Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
- (2009) Matthew Falagas et al. CURRENT DRUG METABOLISM
- Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
- (2009) Scott A. Weisenberg et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns
- (2009) Khetam Hussein et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
- (2009) Leanne B. Gasink et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
- (2009) Abraham Borer et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult
- (2009) Shmuel Benenson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden
- (2009) O. Samuelsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system
- (2009) A. Endimiani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
- (2009) Jason A. Roberts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis
- (2009) B. A. Cunha JOURNAL OF CLINICAL MICROBIOLOGY
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Fatal cross infection by carbapenem-resistantKlebsiellain two liver transplant recipients
- (2009) A.J. Mathers et al. Transplant Infectious Disease
- First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States
- (2008) S. Navon-Venezia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
- (2008) Gopi Patel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Klebsiella pneumoniae Carbapenemase–Producing Organisms: An Ounce of Prevention Really Is Worth a Pound of Cure
- (2008) Arjun Srinivasan et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tigecycline pharmacokinetic/pharmacodynamic update
- (2008) A. P. MacGowan JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
- (2008) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Suboptimal Aminoglycoside Dosing in Critically Ill Patients
- (2008) Rhonda S Rea et al. THERAPEUTIC DRUG MONITORING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started